Metraipolis › archive › dc_e2ae7e09fb47

Machine Learning in Preclinical Development of Antiviral Peptide Candidates: A Review of the Current Landscape — Europe PMC PMID:41754603

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754603
DOI
10.3390/v18020260
License (as archived)
solo-consultazione
Archived
2026-11-05T15:27:44.559Z
SHA-256 of the archived text
1ab38c0e461f36a436535f327dcf52aeb6cf65328b9498feb330ef65d8049051
Stable URL of this page
https://metraipolis.com/documento/dc_e2ae7e09fb47

How to cite

Machine Learning in Preclinical Development of Antiviral Peptide Candidates: A Review of the Current Landscape — Europe PMC PMID:41754603 — Europe PMC (en), https://europepmc.org/article/MED/41754603 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2ae7e09fb47 (Metraipolis archive dc_e2ae7e09fb47, sha256 1ab38c0e461f36a436535f327dcf52aeb6cf65328b9498feb330ef65d8049051)
BibTeX
@misc{dce2ae7e09fb47,
  title = {Machine Learning in Preclinical Development of Antiviral Peptide Candidates: A Review of the Current Landscape — Europe PMC PMID:41754603},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754603},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2ae7e09fb47; sha256 1ab38c0e461f36a436535f327dcf52aeb6cf65328b9498feb330ef65d8049051},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754603. Agents can read the archived copy with the MCP tool read_document.